Page 8 - Glycomimetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GlycoMimetics (NASDAQ:GLYC) Now Covered by Capital One Financial

Capital One Financial initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a report released on Friday morning, Marketbeat reports. The firm issued an overweight rating and a $12.00 price objective on the biotechnology company’s stock. Separately, StockNews.com cut GlycoMimetics from a hold rating to a sell rating in a report on Monday, […]

United statesNew yorkFirst manhattan coMarshall waceGlycomimetics incCapital one financialFree reportGet free reportSigma advisersTwo sigma investmentsSigma investmentsGlycomimetics dailyNasdaq glycInitiated coverageCapital one financial co

Head to Head Contrast: NLS Pharmaceutics (NASDAQ:NLSP) and GlycoMimetics (NASDAQ:GLYC)

Head to Head Contrast: NLS Pharmaceutics (NASDAQ:NLSP) and GlycoMimetics (NASDAQ:GLYC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesApollomics hong kongNational cancer instituteGlycomimetics incGet free reportGiven glycomimeticHong kong

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology A

ROCKVILLE, Md. (BUSINESS WIRE) GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American Society of Hematology (ASH) Annual Meeting will feature two presentations o.

Baylor college of medicineUnited statesNew zealand generalNew zealandEdwin rockEmmanuel almanza huanteMicheles redellLeo vartorellaSan diego convention centerCompany annual report on formGlycomimetics incLeukemia lymphoma societyExchange commissionChinese national medical products administrationDrug administrationDepartment of leukemia

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia

GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American.

United statesEdwin rockNew zealand generalNew zealandBaylor college of medicineMicheles redellEmmanuel almanza huanteGlycomimetics incSan diego convention centerChinese national medical products administrationDrug administrationUniversity of texas md anderson cancer centerCompany annual report on formExchange commissionLeukemia lymphoma societyTexas children cancer center

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

North vancouverBritish columbiaUnited statesNew yorkEdwin rockNew zealandBaylor college of medicineBarbara shecterJoe oconnorGabriel friedmanEmmanuel almanza huanteGeoff cookLeo vartorellaMicheles redellCanada revenue agencyAmerican society of hematology